Antibiotics after assisted births
could stop thousands of infections
Send a link to a friend
[May 14, 2019]
LONDON (Reuters) - Giving a single dose of
antibiotics to mothers who have a medically assisted birth using forceps
or vacuum could prevent almost half of maternal infections, researchers
said on Monday, and global health authorities should change their
advice.
|
In a study published in The Lancet medical journal, the researchers
said prescribing antibiotics as a preventative measure could save
more than 7,000 infections in new mothers in the UK each year, and
around 5,000 in the United States.
They called on the World Health Organization (WHO) and other
national health agencies to alter their advice in the light of the
results.
Current infection rates after assisted vaginal birth without
antibiotic use are around 16% percent globally, and up to 25% after
caesarian section.
In 2016, the researchers said, around 19,500 women worldwide died
because of pregnancy-related infections. And for every woman who
dies from such an infection, another 70 develop a severe infection
and can suffer long-term complications.
This study involved 3,420 women in Britain. As well as the
prevention of sometimes life-threatening infections, it also found
that for every 100 doses of antibiotic given prophylactically, 168
doses could be avoided in future due to fewer post-delivery
infections.
[to top of second column] |
This would mean that a policy of universal prophylaxis after
assisted birth could reduce antibiotic use by 17 percent, the
researchers said.
"These findings highlight the urgent need to change current
...guidelines," said Marian Knight of Britain's Oxford University,
who led the work.
"Pregnancy-associated infection is a major cause of death and
serious illness...Our results show this could be reduced by almost
half by a single dose of prophylactic antibiotic."
(Reporting by Kate Kelland, editing by Mark Heinrich)
[© 2019 Thomson Reuters. All rights
reserved.] Copyright 2019 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
|